Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|February 25, 2022
What Clonal Hematopoiesis Can Teach Us About MDSIrenaeus C C Chan, Brian J Wiley, Kelly L Bolton
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 29, 2024
Social, Behavioral, and Clinical Risk Factors Are Associated with Clonal HematopoiesisCorey D Young, Aubrey K Hubbard, Pedro F Saint-Maurice, et al.
BMC Public Health|March 10, 2009
Smoking, drinking and body weight after re-employment: does unemployment experience and compensation make a difference?Kelly L Bolton, Eunice Rodriguez
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2024
Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201)Jeffrey L Jensen, Olivia Bobek, Irenaeus C C Chan, et al.
Leukemia Research|November 13, 2023
How low can you go?: Methodologic considerations in clonal hematopoiesis variant callingJ Scott Beeler, Kelly L Bolton
Blood|August 1, 2020
What to tell your patient with clonal hematopoiesis and why: insights from 2 specialized clinicsDavid P Steensma, Kelly L Bolton
Blood Advances|June 3, 2024
Impact of cancer therapy on clonal hematopoiesis mutations and subsequent clinical outcomesKevin T Nead, Taebeom Kim, LiJin Joo, et al.
Nature Genetics|March 12, 2026
CDK4/6 inhibition mitigates chemotherapy-induced expansion of TP53-mutant clonal hematopoiesisIrenaeus C C Chan, Pu Zhang, Xiangyu Pan, et al.
Blood|July 6, 2026
Decentralized Clinical Trials in Hematology: the Promise and the PerilGiulia Petrone, Geoffrey L Uy, Kelly L Bolton
Bioinformatics (Oxford, England)|March 14, 2024
ArCH: improving the performance of clonal hematopoiesis variant calling and interpretationIrenaeus C C Chan, Alex Panchot, Evelyn Schmidt, et al.
Pageof 7